151 related articles for article (PubMed ID: 17229043)
1. Venous thrombotic complications in adults undergoing induction treatment for acute lymphoblastic leukemia: results from a meta-analysis.
Caruso V; Iacoviello L; Di Castelnuovo A; Storti S; Donati MB
J Thromb Haemost; 2007 Mar; 5(3):621-3. PubMed ID: 17229043
[No Abstract] [Full Text] [Related]
2. Prothrombotic risk factors in children with acute lymphoblastic leukemia treated with delayed E. coli asparaginase (COALL-92 and 97 protocols).
Mauz-Körholz C; Junker R; Göbel U; Nowak-Göttl U
Thromb Haemost; 2000 Jun; 83(6):840-3. PubMed ID: 10896235
[TBL] [Abstract][Full Text] [Related]
3. Effect of glucocorticoids, E. coli- and Erwinia L-asparaginase on hemostatic proteins in children with acute lymphoblastic leukemia.
Mall V; Thomas KB; Sauter S; Niemeyer CM; Sutor AH
Klin Padiatr; 1999; 211(4):205-10. PubMed ID: 10472551
[TBL] [Abstract][Full Text] [Related]
4. Clinical Course of Cerebral Venous Thrombosis in Adult Acute Lymphoblastic Leukemia.
Zuurbier SM; Lauw MN; Coutinho JM; Majoie CB; van der Holt B; Cornelissen JJ; Middeldorp S; Biemond BJ; Stam J
J Stroke Cerebrovasc Dis; 2015 Jul; 24(7):1679-84. PubMed ID: 25934140
[TBL] [Abstract][Full Text] [Related]
5. Thrombotic effects of asparaginase in two acute lymphoblastic leukemia protocols (NOPHO ALL-1992 versus NOPHO ALL-2000): a single-institution study.
Ruud E; Holmstrøm H; de Lange C; Natvig S; Albertsen BK; Wesenberg F
Pediatr Hematol Oncol; 2006; 23(3):207-16. PubMed ID: 16517537
[TBL] [Abstract][Full Text] [Related]
6. Antimetabolite-based therapy in childhood T-cell acute lymphoblastic leukemia: a report of POG study 9296.
Winter SS; Holdsworth MT; Devidas M; Raisch DW; Chauvenet A; Ravindranath Y; Ducore JM; Amylon MD
Pediatr Blood Cancer; 2006 Feb; 46(2):179-86. PubMed ID: 16007607
[TBL] [Abstract][Full Text] [Related]
7. Risk factors of central venous lines-related thrombosis in children with acute lymphoblastic leukemia during induction therapy: a prospective study.
Farinasso L; Bertorello N; Garbarini L; Gajno TM; Barisone E; Artesani L; Valori A; Giacchino M; Pastore G; Saracco P
Leukemia; 2007 Mar; 21(3):552-6. PubMed ID: 17268522
[No Abstract] [Full Text] [Related]
8. Weekly polyethylene glycol conjugated L-asparaginase compared with biweekly dosing produces superior induction remission rates in childhood relapsed acute lymphoblastic leukemia: a Pediatric Oncology Group Study.
Abshire TC; Pollock BH; Billett AL; Bradley P; Buchanan GR
Blood; 2000 Sep; 96(5):1709-15. PubMed ID: 10961868
[TBL] [Abstract][Full Text] [Related]
9. Thrombotic events are not exclusive to the remission induction period in patients with acute lymphoblastic leukemia: a report of two cases of cerebral sinus thrombosis.
Corso A; Castagnola C; Bernasconi C
Ann Hematol; 1997 Sep; 75(3):117-9. PubMed ID: 9368481
[TBL] [Abstract][Full Text] [Related]
10. Cerebral venous thrombosis in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma during induction chemotherapy with l-asparaginase: The GRAALL experience.
Couturier MA; Huguet F; Chevallier P; Suarez F; Thomas X; Escoffre-Barbe M; Cacheux V; Pignon JM; Bonmati C; Sanhes L; Bories P; Daguindau E; Dorvaux V; Reman O; Frayfer J; Orvain C; Lhéritier V; Ifrah N; Dombret H; Hunault-Berger M; Tanguy-Schmidt A
Am J Hematol; 2015 Nov; 90(11):986-91. PubMed ID: 26214580
[TBL] [Abstract][Full Text] [Related]
11. Risk of thrombosis in pediatric ALL patients--is there a problem!
Mathew P
Vnitr Lek; 2006 Mar; 52 Suppl 1():132-3. PubMed ID: 16637462
[No Abstract] [Full Text] [Related]
12. Bleeding and thrombosis in children with acute lymphoblastic leukaemia, treated according to the ALL-BFM-90 protocol.
Sutor AH; Mall V; Thomas KB
Klin Padiatr; 1999; 211(4):201-4. PubMed ID: 10472550
[TBL] [Abstract][Full Text] [Related]
13. [Venous thrombosis as a complication of L-asparaginase treatment in a child].
Martínez León MI; Alonso Murciano A
Radiologia; 2012; 54(4):372-4. PubMed ID: 21724215
[No Abstract] [Full Text] [Related]
14. An antithrombin replacement strategy during asparaginase therapy for acute lymphoblastic leukemia is associated with a reduction in thrombotic events.
Farrell K; Fyfe A; Allan J; Tait RC; Leach M
Leuk Lymphoma; 2016 Nov; 57(11):2568-74. PubMed ID: 27078747
[TBL] [Abstract][Full Text] [Related]
15. Successful treatment of acute lymphoblastic leukemia with L-asparaginase-induced intracranial hemorrhage to activated recombinant factor VIIa in a child.
Ucar C; Caliskan U
Pediatr Hematol Oncol; 2006 Jun; 23(4):339-45. PubMed ID: 16621776
[TBL] [Abstract][Full Text] [Related]
16. Hypersensitivity reactions to L-asparaginase do not impact on the remission duration of adults with acute lymphoblastic leukemia.
Larson RA; Fretzin MH; Dodge RK; Schiffer CA
Leukemia; 1998 May; 12(5):660-5. PubMed ID: 9593262
[TBL] [Abstract][Full Text] [Related]
17. [The programmed therapy of acute lymphoblastic leukemia in adults].
Isaev VG; Savchenko VG; Kucher RA; Abakumov EM; Parovichnikova EN
Ter Arkh; 1992; 64(8):82-7. PubMed ID: 1440405
[No Abstract] [Full Text] [Related]
18. Incidence of asparaginase-related hepatotoxicity, pancreatitis, and thrombotic events in adults with acute lymphoblastic leukemia treated with a pediatric-inspired regimen.
Christ TN; Stock W; Knoebel RW
J Oncol Pharm Pract; 2018 Jun; 24(4):299-308. PubMed ID: 28355969
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of post-thrombotic syndrome following asymptomatic thrombosis in survivors of acute lymphoblastic leukemia.
Kuhle S; Spavor M; Massicotte P; Halton J; Cherrick I; Dix D; Mahoney D; Bauman M; Desai S; Mitchell LG
J Thromb Haemost; 2008 Apr; 6(4):589-94. PubMed ID: 18194413
[TBL] [Abstract][Full Text] [Related]
20. Lipid Apheresis to Manage Severe Hypertriglyceridemia during Induction Therapy in a Child with Acute Lymphoblastic Leukemia.
Mayerhofer C; Speckmann C; Kapp F; Teufel-Schäfer U; Kluwe W; Schneider J; Flotho C
Pediatr Hematol Oncol; 2020 Sep; 37(6):530-538. PubMed ID: 32374222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]